Clinical Trial Update: FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing FOLFOXIRI with or without panitumumab in metastatic colorectal cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFOXIRI (folinic acid (leucovorin), fluorouracil (5-FU), oxaliplatin, irinotecan)
• Panitumumab (panitumumab)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED